IOP Monitoring After Trabeculectomy Using iCare Home

Status Terminated

Clinical Trial Summary

The purpose of this study is to investigate how much trabeculectomy influences intraocular pressure (IOP) fluctuations measured with iCare Home rebound tonometry (RTHome) in patients with primary open-angle glaucoma (POAG) or pseudo-exfoliation glaucoma (PEX).

Clinical Trial Description

Fifty glaucoma patients (POAG and PEX) planned for trabeculectomy will be recruited. At baseline, patients will be trained to use the iCare Home tonometer (RTHome), a handheld device based on rebound tonometry and designed for patients to use at home. After the training session and when patients feel confident, a measurement will be recorded. At the same visit, a new measurement will be obtained by the study staff, an optometrist or a nurse, using the same device. No IOP values will be visible for the examiner at that point. A single IOP measurement will be obtained by the same study staff using Goldmann applanation tonometry (GAT). Patients will come for a second visit where new measurements will be made in the same way as at baseline. In between visits, patients will borrow the iCare Home tonometer to measure their IOP at 06 and 10 am, and at 2, 6 and 10 pm during three consecutive days to obtain an IOP curve. Two-three months after trabeculectomy, a new IOP curve will be obtained following the same procedure as pre-operatively. There will be no restrictions in patients' daily activities regarding diet, physical activity or slee. If patients use any eyedrops, they will continue to use them as prescribed. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03445806
Study type	Observational
Source	St. Erik Eye Hospital
Contact
Status	Terminated
Phase
Start date	February 26, 2018
Completion date	March 22, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05044793` - A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System
Recruiting	`NCT06201455` - Evaluation of Phacogoniotomy in Medically-controlled POAG	N/A
Recruiting	`NCT03369886` - The Relationship Between Macular OCTA and GCIPL and Their Combinational Index Using AI	N/A
Active, not recruiting	`NCT04624698` - iStent Inject New Enrollment Post-Approval Study	N/A
Recruiting	`NCT02679482` - Following Patients After Selective and Pascal Laser Trabeculoplasty for Treatment of Chronic Open-Angle Glaucoma	N/A
Completed	`NCT02338362` - Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled Glaucoma	Phase 4
Active, not recruiting	`NCT01430923` - Clinical Evaluation of Safety and Efficacy of Refrigeration Free Latanoprost	N/A
Completed	`NCT01489670` - Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension	N/A
Completed	`NCT00753168` - Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma	Phase 1/Phase 2
Completed	`NCT00693485` - Safety and Effects of Brimonidine Intravitreal Implant in Patients With Glaucomatous Optic Neuropathy	Phase 2
Completed	`NCT00051194` - A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension	Phase 2
Recruiting	`NCT04920227` - Comparation of CLASS Combined With Phacoemulsification and CLASS Alone in the Treatment of Primary Open Angle Glaucoma	N/A
Active, not recruiting	`NCT03868124` - Clinical Study Comparing Two Models of a Travoprost Intraocular Implant	Phase 3
Completed	`NCT03267862` - Scleral Response to Intraocular Pressure (IOP)	N/A
Recruiting	`NCT06066645` - Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone	Phase 3
Recruiting	`NCT04912362` - The Effectiveness of YAG Iridotomy in Preventing Peripheral Anterior Synechia After CLASS in Primary Open Angle Glaucoma	N/A
Completed	`NCT04949802` - Glaucoma Surgery Using the ViaLase Laser System	N/A
Recruiting	`NCT04038034` - Valuation of the Antioxidant and Neuroprotective Effects of CoQ10-MINIACTIVES® (COQUN® OS) in Patients Affected by Primary Open Angle Glaucoma	N/A
Completed	`NCT04632329` - Negative Pressure Applied by the Equinox MPD for Severe Open Angle Glaucoma	N/A
Completed	`NCT01215786` - Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma	Phase 1